History
  • No items yet
midpage
Japanese Foundation for Cancer Research v. Lee
773 F.3d 1300
| Fed. Cir. | 2014
Read the full case

Background

  • The ’187 patent (U.S. Patent No. 6,194,187) was owned by the Japanese Foundation for Cancer Research. On Oct. 11, 2011 the Foundation’s attorney of record filed a terminal disclaimer under 37 C.F.R. § 1.321(a) disclaiming the entire term of the patent’s claims.
  • In Dec. 2011 the Foundation filed a petition under 37 C.F.R. § 1.182 to withdraw the disclaimer, asserting it was mistakenly filed and unauthorized; the PTO denied the petition in Jan. 2012.
  • The Foundation submitted declarations from its licensee’s counsel and others claiming the disclaimer resulted from miscommunication and a paralegal’s mistaken research and that the Foundation did not authorize the disclaimer.
  • The PTO rejected reopening or withdrawing the recorded disclaimer, relying on its practice that no mechanism exists to withdraw a recorded terminal disclaimer (except narrow correction scenarios) and noting the disclaimer met regulatory signing and fee requirements.
  • The Foundation unsuccessfully sought discretionary relief and argued § 255 (certificate of correction) or inherent PTO authority could permit withdrawal; the district court granted relief but the Federal Circuit reversed.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Availability of 35 U.S.C. § 255 (certificate of correction) to withdraw a terminal disclaimer § 255 covers "clerical or typographical" errors and thus can correct a mistakenly filed disclaimer (paralegal error) § 255 applies to facial clerical/typographical errors in the patent document, not to undo a properly executed filing; MPEP and precedent limit § 255 Held: § 255 does not authorize withdrawal of this terminal disclaimer; no facial clerical error here
Whether PTO has inherent/discretionary authority to withdraw an effectively recorded disclaimer PTO has inherent authority and should exercise discretion given the asserted mistake and lack of authorization PTO may reconsider only in limited scenarios; once requirements (signature, fee, form) met, PTO will not nullify disclaimer for attorney-client miscommunications; public reliance concerns Held: PTO did not abuse discretion; it permissibly declined to withdraw the disclaimer
Relevance of whether disclaimer had been processed/published when petition filed Withholding publication and processing means withdrawal is appropriate because public reliance was minimal Filing date, not processing date, determines that disclaimer is recorded if in proper form with fee; processing delay does not change effect Held: Vectra controls; disclaimer was effective when filed, so PTO reasonably treated it as recorded
Whether client may avoid consequences of attorney-of-record actions (authorization issue) Client should not be bound where attorney acted without client authorization and caused loss of property right Regulations authorize attorney/agent of record to file disclaimers; clients are bound by actions of voluntarily chosen representative; remedies lie against attorney (malpractice) Held: PTO reasonably refused to inquire into internal client-attorney communications and held client bound; agency acted within discretion

Key Cases Cited

  • Carnegie Mellon Univ. v. Schwartz, 105 F.3d 863 (3d Cir. 1997) (describes PTO granting withdrawal/correction where disclaimer identified wrong patent number)
  • Vectra Fitness, Inc. v. TNWK Corp., 162 F.3d 1379 (Fed. Cir. 1998) (a disclaimer is "recorded" when properly filed with PTO; stresses finality and certainty of disclaimers)
  • Superior Fireplace Co. v. Majestic Prods. Co., 270 F.3d 1358 (Fed. Cir. 2001) (interpreting "clerical or typographical" in § 255 as facial, obvious mistakes)
  • Ford Motor Co. v. United States, 157 F.3d 849 (Fed. Cir. 1998) (interpreting "clerical error" in another statutory context as acts by subordinates contrary to binding instructions)
  • Tokyo Kikai Seisakusho, Ltd. v. United States, 529 F.3d 1352 (Fed. Cir. 2008) (agencies possess inherent authority to reconsider decisions subject to limits)
  • Bowman Transp., Inc. v. Ark.-Best Freight Sys., Inc., 419 U.S. 281 (U.S. 1974) (arbitrary and capricious review is narrow and courts should not substitute their judgment for agencies')
  • SEC v. Chenery Corp., 332 U.S. 194 (U.S. 1947) (courts must uphold agency action on any valid ground articulated by the agency)
  • Motor Vehicle Mfrs. Ass'n v. State Farm Mut. Auto. Ins. Co., 463 U.S. 29 (U.S. 1983) (agency must examine relevant data and articulate a satisfactory explanation)
  • Vt. Yankee Nuclear Power Corp. v. Natural Res. Def. Council, Inc., 435 U.S. 519 (U.S. 1978) (courts cannot force agencies to employ procedures beyond statutory requirements)
  • Link v. Wabash R.R. Co., 370 U.S. 626 (U.S. 1962) (client's remedy for attorney misconduct is malpractice action)
Read the full case

Case Details

Case Name: Japanese Foundation for Cancer Research v. Lee
Court Name: Court of Appeals for the Federal Circuit
Date Published: Dec 9, 2014
Citation: 773 F.3d 1300
Docket Number: 2013-1678, 2014-1014
Court Abbreviation: Fed. Cir.